Telomir Pharmaceuticals, Common Stock Price on November 26, 2024
| TELO Stock | 4.28 0.17 3.82% |
If you're considering investing in Telomir Stock, it is important to understand the factors that can impact its price. As of today, the current price of Telomir Pharmaceuticals, stands at 4.28, as last reported on the 29th of November, with the highest price reaching 4.51 and the lowest price hitting 3.86 during the day. As of now, Telomir Stock is very risky. Telomir Pharmaceuticals, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0034, which indicates the firm had a 0.0034% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Telomir Pharmaceuticals, Common, which you can use to evaluate the volatility of the company. Please validate Telomir Pharmaceuticals,'s Variance of 54.76, coefficient of variation of (12,176), and Risk Adjusted Performance of 0.0027 to confirm if the risk estimate we provide is consistent with the expected return of 0.0259%.
At this time, Telomir Pharmaceuticals,'s Total Stockholder Equity is very stable compared to the past year. As of the 29th of November 2024, Other Stockholder Equity is likely to grow to about 21.1 M, while Common Stock Shares Outstanding is likely to drop about 23.7 M. . At this time, Telomir Pharmaceuticals,'s Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price To Book Ratio is likely to grow to 63.30, while Price Earnings Ratio is likely to drop (16.65). Telomir Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Telomir |
Sharpe Ratio = 0.0034
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TELO |
Estimated Market Risk
| 7.53 actual daily | 67 67% of assets are less volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Telomir Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telomir Pharmaceuticals, by adding Telomir Pharmaceuticals, to a well-diversified portfolio.
Price Book 114.6564 | Book Value 0.053 | Enterprise Value 179.8 M | Shares Float 17.5 M | Shares Outstanding 29.6 M |
Related Headline
Hurco Companies Headline on 26th of November 2024
Disposition of 836 shares by Michael Doar of Hurco Companies... by MacroaxisInsider
Filed transaction by Hurco Companies Director, Officer Executive Chairman. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Telomir Pharmaceuticals, Valuation on November 26, 2024
It is possible to determine the worth of Telomir Pharmaceuticals, on a given historical date. On November 26, 2024 Telomir was worth 4.56 at the beginning of the trading date compared to the closed value of 4.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Telomir Pharmaceuticals, stock. Still, in general, we apply an absolute valuation method to find Telomir Pharmaceuticals,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Telomir Pharmaceuticals, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Telomir Pharmaceuticals,'s related companies.
| Open | High | Low | Close | Volume | |
| 4.34 | 4.51 | 4.30 | 4.49 | 243,653 | |
11/26/2024 | 4.56 | 4.73 | 4.26 | 4.45 | 227,234 |
| 4.51 | 4.51 | 3.86 | 4.28 | 288,253 |
| Backtest Telomir Pharmaceuticals, | | | Telomir Pharmaceuticals, History | | | Telomir Pharmaceuticals, Valuation | Previous | Next |
Telomir Pharmaceuticals, Trading Date Momentum on November 26, 2024
| On November 27 2024 Telomir Pharmaceuticals, Common was traded for 4.28 at the closing time. The top price for the day was 4.51 and the lowest listed price was 3.86 . The trading volume for the day was 288.3 K. The trading history from November 27, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.82% . The trading price change against the current closing price is 1.35% . |
Telomir Pharmaceuticals, Fundamentals Correlations and Trends
By evaluating Telomir Pharmaceuticals,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Telomir Pharmaceuticals,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Telomir financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Telomir Pharmaceuticals, Stock history
Telomir Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telomir is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telomir Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telomir Pharmaceuticals, stock prices may prove useful in developing a viable investing in Telomir Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 23.7 M |
Telomir Pharmaceuticals, Stock Technical Analysis
Telomir Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Telomir Pharmaceuticals, Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Telomir Pharmaceuticals, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Telomir Pharmaceuticals, November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Telomir Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telomir Pharmaceuticals, shares will generate the highest return on investment. By undertsting and applying Telomir Pharmaceuticals, stock market strength indicators, traders can identify Telomir Pharmaceuticals, Common entry and exit signals to maximize returns
Telomir Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Telomir Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of Telomir Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telomir to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0027 | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (1.18) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.84) | Return On Equity (6.87) |
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.